Matinas BioPharma Holdings Inc (MTNB)

US · Healthcare · Biotechnology

$1.19+2.59%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.3M

EPS

$-0.21

Market cap

$1.1M

Forward P/E

0.0

P/B

0.63

Book value

$4.21

EPS (TTM)

$-17.55

52-week high

$19.95

52-week low

$0.97

50-day MA

$2.41

200-day MA

$6.86

Beta

2.25

Analysts rate Matinas BioPharma Holdings Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $30.00.

Insiders

23.75%

Institutions

2.21%

Action	Detail	Date
Split	1 : 15 effective Sep 28, 2026	2026-09-28

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Matinas BioPharma Holdings Inc — free to start.

Data updated 2026-11-07.